Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study

Beverley M. Shields, Catherine D. Angwin, Maggie H. Shepherd, Nicky Britten, Angus G. Jones, Naveed Sattar, Rury Holman, Ewan R. Pearson, Andrew T. Hattersley (Lead / Corresponding author)

Population Health and Genomics

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

85 Downloads (Pure)

2 results

Finished
Stratified Medicine in Type 2 Diabetes: Insights from the Study of Drug Response (New Investigator Award)
Pearson, E. (Investigator)
16/02/15 → 15/08/21
Project: Research
MASTER MIND - MRC ABPI Stratification and Extreme Response Mechanism in Type 2 Diabetes (Joint with University of Exeter, Newcastle University, Kings College London, University of Oxford and University of Glasgow)
Morris, A. (Investigator), Palmer, C. (Investigator) & Pearson, E. (Investigator)
Medical Research Council
25/02/13 → 31/05/21
Project: Research